Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Msi2 maintains the MLL leukemia stem cell regulatory program
    Meeting Abstract

    Park, S. M.; Gonen, M.; Vu, L. P.; Minuesa, G.; Tivnan, P.; Barlowe, T.; Taggart, J.; Lu, Y. H.; Deering, R. P.; Hacohen, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • CD19-targeted 19-28z CAR modified autologous T cells induce high rates of complete remission and durable responses in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y. J.; Yoo, S.; Purdon, T.; Halton, E.; Quintanilla, H.; Curran, K. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • An international data set for the study of chronic myelomonocytic leukemia (CMML) validates modern prognostic scoring systems and demonstrates a critical need for novel prognostication strategies
    Meeting Abstract

    Padron, E.; Garcia-Manero, G.; Patnaik, M. M.; Itzykson, R.; Lasho, T.; Nazha, A.; Rampal, R. K.; Sanchez, M. E.; Jabbour, E.; Al Ali, N. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • An oncogene-regulated epigenetic switch in T cell acute lymphoblastic leukemia
    Meeting Abstract

    Ntziachristos, P.; Tsirigos, A.; Welstead, G.; Trimarchi, T.; Holmfeldt, L.; Satoh, T.; Paietta, E. M.; Tallman, M. S.; Rowe, J. M.; Tonon, G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Specific and recurrent cytogenomic abnormalities originate in the spleens of myelofibrosis patients and contribute to clonal diversity and disease progression
    Meeting Abstract

    Najfeld, V.; Tripodi, J.; Wang, X. L.; Schwartz, M.; Kremyanskaya, M.; Cytryn, E.; Zirkiev, S.; Rampal, R. K.; Mascarenhas, J. O.; Hoffman, R.
    Blood (2014)

    Fulltext@MSK | Save
  • Prediction of CD34(+) hematopoietic progenitor cell harvest yield in multiple myeloma patients mobilized with G-CF and plerixafor
    Meeting Abstract

    Moung, C.; Avecilla, S. T.; Meagher, R. C.; Reich, L.; Maslak, P.
    Transfusion (2014)

    Fulltext@MSK | Save
  • Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Deep molecular response in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib: ENESTnext update
    Meeting Abstract

    Mauro, M. J.; Dakhil, S.; Cortes, J. E.; Rizzieri, D. A.; Keir, C. H.; Yi, S.; Heinrich, M. C.; Goldberg, S. L.; Catchatourian, R.; Kuriakose, P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Ponatinib efficacy and safety in patients with the T315I mutation: Long-term follow-up of phase 1 and phase 2 (PACE) trials
    Meeting Abstract

    Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Baccarani, M.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Kantarjian, H. M.; Shah, N. P.; Bixby, D.; more...
    Blood (2014)

    Fulltext@MSK | Save